Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran.
Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
PLoS One. 2024 Oct 24;19(10):e0309292. doi: 10.1371/journal.pone.0309292. eCollection 2024.
Type II toxin-antitoxin systems such as mazEF3, vapBC3, and relJK play a role in antibiotic resistance and tolerance. Among the different known TA systems, mazEF3, vapBC3, and relJK, which are type II systems, have specific roles in drug resistance. Therefore, the aim of this study was to investigate the mutations in these genes in sensitive and resistant isolates of Mycobacterium tuberculosis. Thirty-two rifampin-resistant and 121 rifampin-sensitive M. tuberculosis isolates were collected from various regions of Iran. Lineage typing was performed using the ASO-PCR method. Mutations in the rpoB gene were analyzed in all isolates by MAS-PCR. Furthermore, mutations in the mazEF3, relJK, and vapBC3 genes of the type II toxin system were assessed through PCR sequencing. These sequences were analyzed using COBALT and SnapGene 2017, and submitted to the GenBank database. Among the 153 M. tuberculosis samples, lineages 4, 3 and 2 were the most common. Lineage 2 had the highest rate of rifampin resistance. Mutations in rpoB531 were the most frequent in resistant isolates. Examination of the toxin-antitoxin system showed that rifampin-resistant isolates belonging to lineage 3 had mutations in either the toxin or antitoxin parts of all three TA systems. A mutation in nucleotide 195 (codon 65) of mazF3 leading to an amino acid change from threonine to isoleucine was detected in all rifampin-resistant isolates. M. tuberculosis isolates belonging to lineage 2 exhibited the highest rifampin resistance in our study. Identifying the mutation in mazF3 in all rifampin-resistant isolates can highlight the significance of this mutation in the development of drug resistance in M. tuberculosis. Expanding the sample size in future studies can help develop a new method for identifying resistant isolates.
II 型毒素-抗毒素系统,如 mazEF3、vapBC3 和 relJK,在抗生素耐药性和耐受性中发挥作用。在已知的不同 TA 系统中,mazEF3、vapBC3 和 relJK 作为 II 型系统,在耐药性方面具有特定作用。因此,本研究旨在研究结核分枝杆菌敏感和耐药分离株中这些基因的突变。从伊朗不同地区收集了 32 株利福平耐药和 121 株利福平敏感的结核分枝杆菌分离株。采用 ASO-PCR 法进行谱系分型。采用 MAS-PCR 分析所有分离株 rpoB 基因的突变。此外,通过 PCR 测序评估了 II 型毒素系统 mazEF3、relJK 和 vapBC3 基因的突变。这些序列使用 COBALT 和 SnapGene 2017 进行分析,并提交给 GenBank 数据库。在 153 株结核分枝杆菌样本中,谱系 4、3 和 2 最为常见。谱系 2 的利福平耐药率最高。耐药分离株中 rpoB531 突变最为常见。对毒素-抗毒素系统的检查表明,属于谱系 3 的利福平耐药分离株在三个 TA 系统的毒素或抗毒素部分均发生突变。在所有利福平耐药分离株中均检测到 mazF3 中核苷酸 195(密码子 65)的突变,导致苏氨酸变为异亮氨酸。本研究中,属于谱系 2 的结核分枝杆菌分离株表现出最高的利福平耐药性。在所有利福平耐药分离株中鉴定出 mazF3 的突变,可以突出该突变在结核分枝杆菌耐药性发展中的重要性。在未来的研究中扩大样本量可以帮助开发一种新的方法来鉴定耐药分离株。